login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
COSMOS HEALTH INC (COSM) Stock News
USA
-
Nasdaq
- NASDAQ:COSM -
US2214133058
-
Common Stock
0.4616
USD
-0.03 (-6.94%)
Last: 12/5/2025, 8:11:43 PM
0.4726
USD
+0.01 (+2.38%)
After Hours:
12/5/2025, 8:11:43 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
COSM Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Cosmos Health Inc.
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
4 days ago - By: Cosmos Health Inc.
Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets
5 days ago - By: Cosmos Health Inc.
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
5 days ago - By: Cosmos Health Inc.
Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases
20 days ago - By: Cosmos Health Inc.
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
20 days ago - By: Cosmos Health Inc.
Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M
a month ago - By: Cosmos Health Inc.
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
a month ago - By: Cosmos Health Inc.
Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy
2 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
2 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
2 months ago - By: Cosmos Health Inc.
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement
2 months ago - By: Cosmos Health Inc.
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
2 months ago - By: Cosmos Health Inc.
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
2 months ago - By: Cosmos Health Inc.
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
2 months ago - By: Cosmos Health Inc.
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
2 months ago - By: Benzinga
- Mentions:
IVA
ABP
ONMD
VTVT
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
2 months ago - By: Benzinga
- Mentions:
PRPH
ABP
WORX
TRVI
...
12 Health Care Stocks Moving In Friday's After-Market Session
2 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
2 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units
2 months ago - By: Cosmos Health Inc.
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
2 months ago - By: Cosmos Health Inc.
Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
2 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually
3 months ago - By: Cosmos Health Inc.
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
3 months ago - By: Cosmos Health Inc.
Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue
3 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
3 months ago - By: Cosmos Health Inc.
Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units
4 months ago - By: Cosmos Health Inc.
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
4 months ago - By: Cosmos Health Inc.
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
4 months ago - By: Cosmos Health Inc.
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
4 months ago - By: Cosmos Health Inc.
Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
4 months ago - By: Cosmos Health Inc.
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
4 months ago - By: Cosmos Health Inc.
Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy
5 months ago - By: Yahoo Finance
- Mentions:
MSFT
Cosmos Health enters U.S. market with DolCas Biotech agreement
6 months ago - By: Cosmos Health Inc.
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
Please enable JavaScript to continue using this application.